Biomarkers associated with COPD include markers of systemic inflammation (CRP and fibrinogen) and indicators of disease activity (airways neutrophils and desmosine), which have also been related to increased vascular risk and atherogenesis [44–46]. The gene discussed is CRP; the disease is chronic obstructive pulmonary disease.